Initiator Pharma AS (OSTO:INIT) EBITDA Margin %: 0.00% (As of Mar. 2026)


OSTO:INIT Initiator Pharma AS OSTO:INIT
24 GF Score
Price kr2.72
! 1 Warning Sign
View Full Analysis

What is Initiator Pharma AS EBITDA Margin %?

Initiator Pharma AS OSTO:INIT -1.45% 24 EBITDA Margin % is 0.00% as of Mar. 2026. GuruFocus rates OSTO:INIT with a GF Score™ of 24/100. The stock has 1 warning sign investors should review. Among 936 Biotechnology companies, Initiator Pharma AS ranks worse than 106837.5% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Initiator Pharma AS's EBITDA for the three months ended in Mar. 2026 was kr-16.46 Mil. Initiator Pharma AS's Revenue for the three months ended in Mar. 2026 was kr0.00 Mil. Therefore, Initiator Pharma AS's EBITDA margin for the quarter that ended in Mar. 2026 was 0.00%.

Initiator Pharma AS  (OSTO:INIT) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Initiator Pharma AS EBITDA Margin % Related Terms

Initiator Pharma AS EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Initiator Pharma AS's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Initiator Pharma AS EBITDA Margin % Chart

Initiator Pharma AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Initiator Pharma AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OSTO:INIT vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, Initiator Pharma AS's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Initiator Pharma AS EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Initiator Pharma AS's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Initiator Pharma AS's EBITDA Margin % falls into.


OSTO:INIT
24GF Score
Initiator Pharma AS OSTO:INIT
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Initiator Pharma AS EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Initiator Pharma AS's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-24.327/0
= %

Initiator Pharma AS's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-16.463/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Initiator Pharma AS (OSTO:INIT) has a EBITDA Margin % of 0.00% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Initiator Pharma AS and its competitors. According to the industry distribution chart, Initiator Pharma AS ranks #999999 out of 936 companies in the Biotechnology industry.
Is Initiator Pharma AS's EBITDA Margin % too high?
Initiator Pharma AS's current EBITDA Margin % is 0.00%. Based on the distribution chart, Initiator Pharma AS ranks #999999 out of 936 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Initiator Pharma AS has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Initiator Pharma AS's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Initiator Pharma AS ranks #999999 out of 936 companies for EBITDA Margin %. This places Initiator Pharma AS in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Initiator Pharma AS and its competitors. Initiator Pharma AS's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Initiator Pharma AS stock overvalued right now?
Initiator Pharma AS (OSTO:INIT) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Initiator Pharma AS's overall GF Score™ is 24/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Initiator Pharma AS (OSTO:INIT), the current EBITDA Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Initiator Pharma AS Business Description

Address Co/ COBIS, Ole Maaloesvej 3, Copenhagen, DNK, 2200
Initiator Pharma AS is a Danish clinical-stage life science company developing drugs that target key unmet medical needs within the central and peripheral nervous system. Its pipeline consists of three clinical programs: IP2018 and pudafensine for the treatment of erectile dysfunction of psychogenic and organic origin, respectively.
24GF Score

Get the complete analysis for OSTO:INIT

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.72
Price